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BACKGROUND: On average, Medicare Supplement in-
sureds take about seven unique prescriptionmedications
each year, resulting in substantial out-of-pocket drug
copayments, in addition to Medicare Supplement and
Part D premiums. To help alleviate this financial burden,
many individuals resort to cost-saving strategies that are
not trackable by Part D insurance plans, likely resulting
in an underestimation of medication adherence rates.
OBJECTIVE: We aimed to estimate utilization rates of
cost-saving strategies, measure member characteristics
associated with these strategies and estimate if these
strategies are associated with medication adherence.
DESIGN: This was a cross-sectional analysis of a 2012–
2013 survey of AARP® Medicare Supplement plan in-
sureds with Part D pharmaceutical coverage.
PARTICIPANTS: The study included 5,784 community-
dwelling survey respondents ≥ 65 years of age, living in
ten states and with self-reported use of prescription
medications.
MAINMEASURES: Self-reported use of cost-saving strat-
egies included: obtaining free samples from physicians,
splitting pills so medications lasted longer, purchasing
medications from other countries and/or over the inter-
net, or purchasing medications through the Veterans Ad-
ministration. Propensity weighted multivariate regres-
sions were utilized to determine characteristics associat-
edwith the use of such strategies and the associationwith
medication adherence asmeasured fromMedicare Part D
claims.
KEYRESULTS: Among those takingmedications, 39.6%
used cost-saving strategies. Those using these strategies
were significantly (p<0.05) more likely to be male, non-
minority, have more comorbid conditions, have more dis-
abilities and use more medications. Few variables were
significantly related to pharmaceutical nonadherence,
but those who were nonadherent were significantly more
likely to usemoremedications, split pills, obtain free sam-
ples from their physicians and be male.
CONCLUSION:Cost-saving strategies are used extensive-
ly as ameans to augmentMedicare PartD coverage. These
strategies are associated with measured medication
nonadherence and likely result in underreporting of med-
ication adherence rates. Pharmacy management pro-
grams should consider these additional medication
sources in assisting plan members to problem solve
cost-related medication management issues.
KEY WORDS: cost-saving strategies; free drug samples; medication
nonadherence; Medicare; Medigap.
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INTRODUCTION
Prescription drugs represent one of the highest out-of-pocket
(OOP) healthcare costs for American consumers, accounting
for about $47 billion dollars in 2012.1 About 90 % of Medicare
Supplement insureds take at least one prescription medication,2
resulting in substantial OOP drug copayments. Medicare Sup-
plement plans are often referred to as “Medigap” plans because
they help to defray the OOP expenses not covered by the fee-for-
service Medicare program; Part D insurance provides prescrip-
tion drug coverage. Among users, Medicare Supplement in-
sureds take about seven unique prescription medications each
year, with medication needs greatest for the older age groups and
those with multiple chronic conditions.2 As a result, 10 % of
insureds average over $1,300 in annual OOP spending on pre-
scription medications.3
With the implementation of Medicare Part D in 2006,
significant improvements in pharmaceutical coverage for the
elderly occurred. However, despite improvements in percent-
ages of those with coverage,4 documented increases in medi-
cation adherence5–7 and significant decreases in OOP spend-
ing,4,5,7–10 11 to 26 % of Medicare insureds continue to self-
report that they skip doses, split pills or do not fill prescriptions
due to cost.11–15 The prevalence of such cost-related
nonadherence (CRN) is even higher among minorities, those
with lower incomes and those in poorer health.10,13,16 Addi-
tional strategies used by older adults to lower OOP spending
include other options, such as requesting free samples from
physicians, splitting pills to make medications last longer,
purchasing medications from other countries and over the
internet, or leveraging other sources of insurance coverage
(e.g., Medicaid or Department of Veterans Affairs [VA] insur-
ance).17–22 These alternative medication sources are generally
not trackable through administrative pharmaceutical claims,
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which impairs the ability to monitor pharmaceutical adherence
by Part D insureds.
Rates of medication nonadherence are highly sensitive to
the cost burden associated with OOP spending—as OOP
spending increases with higher numbers of medications, med-
ication nonadherence increases.22–28 Other factors, such as
demographics (e.g., gender, race), socioeconomics (e.g., in-
come, education), health literacy, depression or other lifestyle
behaviors (e.g., physical activity, smoking), are less consis-
tently associated with medication adherence.9,10,16,27–32 Re-
gardless of reasons why seniors do not comply with recom-
mended protocols, medication nonadherence has consistently
been associated with negative health outcomes, including
increased use of emergency rooms,13 hospitalizations and total
healthcare costs.23,24,33
Most of the literature examining prescription drug purchas-
ing patterns has focused on general Medicare populations.17–21
We found no studies investigating whether disparities regard-
ing utilization of cost-saving strategies exist among older adults
with Medicare Supplement plans (i.e., Medigap). While most
(about 90 %) of those with fee-for-service Medicare coverage
have some type of supplemental insurance coverage, only
about 28 % (about 10.2 million adults) have purchased Med-
igap coverage.34 Thus, those with Medigap coverage represent
a significant portion of the Medicare population. We hypothe-
size that patient demographics, health status and benefit levels
likely differ by Medigap source and plan type, and therefore,
may impact disparities in the utilization of cost-saving strate-
gies compared to the general Medicare populations. Further-
more, to date, multivariate models estimating significant pre-
dictors of medication adherence have not included untrackable
cost-savings strategies, such as obtaining free samples from
physicians or splitting pills.
Considering the importance of OOP spending tomedication
adherence, the primary objective of this study was to estimate
utilization rates of cost-saving strategies among a Medicare
Supplement study population. The secondary objectives in-
cluded determiningmember characteristics associated with the
use of these strategies and estimating the association of these




In 2013, approximately 3.5 million Medicare insureds were
covered by an AARP® Medicare Supplement plan insured by
UnitedHealthcare Insurance Company (for New York resi-
dents, UnitedHealthcare Insurance Company of New York).
These plans are offered in all 50 states, Washington D.C. and
various U.S. territories. A randomly selected sample of 31,000
of these insureds in ten states (Arizona, California, Colorado,
Florida, Missouri, North Carolina, Ohio, New Jersey, New
York and Texas) was surveyed in 2012 and 2013. The
sampling strategy included an eligibility criterion for care
management programs (i.e., oversampling those with more
intensive health needs).
Those surveyed were 65 years or older with a minimum of
3 months of AARP Supplement plan eligibility. To be includ-
ed in this study, survey respondents were also required to have
purchased AARPMedicare Part D prescription drug coverage.
Those who indicated that they were not currently taking pre-
scription medications (8 %) or who didn’t answer the survey
question on cost savings (2 %) were excluded. The final study
sample included 5,784 survey respondents. This study sample
was used to examine prevalence of utilization of cost-saving
strategies and characteristics associated with the use of these
strategies.
To determine medication adherence, survey respondents
were linked to Evidence-Based Medicine (Symmetry EBM
Connect® Version 7.6) software. This software program was
developed to calculate medication adherence based on phar-
maceutical claims. Medication adherence calculations were
limited to those patients with a minimum of one year of
continuous medical enrollment, six months of pharmaceutical
drug coverage and at least two prescriptions for a given
medication with an associated diagnosis (e.g., diabetes). Ten
common primary chronic conditions aligned with those que-
ried on the survey were included in this analysis (see Table 1
for a list of conditions). A subgroup of 4,222 survey respon-
dents was utilized for themedication adherence analysis. To be
considered “adherent,” individuals must have had at least
70 % of the days supplied for the medications within a given
therapeutic drug class. Therapeutic drug classes are a way of
classifying prescription drugs according to their functions in
treating similar medical conditions. We then counted the num-
ber of medications for which each individual was nonadherent
across all categories of prescription medications.
CAHPS Survey
The Consumer Assessment of Healthcare Providers and Sys-
tems (CAHPS) is a survey funded and overseen by the U.S.
Agency for Healthcare Research and Quality (AHRQ). The
survey is designed to query patients and consumers to report
on and evaluate their experiences and satisfaction with Medi-
care delivery systems. The survey is in the public domain and
has become the national standard for measuring and reporting
on patient experiences.
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This self-reported survey measures the member’s demo-
graphics, socioeconomic factors, health status and perception
of experiences and satisfaction with the different components
of healthcare services. The CAHPS survey was adapted for
distribution to our population to identify their health needs and
inform potential interventions. In this study, the following
three questions relevant to our primary and secondary objec-
tives were used:
1. Please mark…each type of health insurance you have in
addition to Medicare and your Medicare Supplement
Insurance Plan: Veteran’s Benefits also known as VA
benefits; Employer, Union or Retiree health coverage
(insurance); Medicare prescription drug plan or other
insurance.
2. “Do you now need or take medicine prescribed by your
doctor?” Yes/No
3. “In the last 6 months, did you ever do any of the
following to save money on your medications? (Check
all that apply).”
& Use mail order
& Use generic medications
& Purchase medications over the internet
& Purchase medication from other countries
& Purchase medications from retail outlets
& Obtain free samples from doctors
& Split pills so medications last longer
& Did something else
& I did not have difficulty paying for medications
Cost-saving strategies were defined as using any of the
following: purchasing medications over the internet or from
other countries; obtaining free samples from doctors; splitting
pills to make medications last longer and using other sources
of insurance coverage (e.g., VA insurance). Using mail order,
generic medications, purchasing from retail outlets and doing
something else were not included as cost-saving strategies.
When repayment is not due, retail pharmacy chains often do
not consistently report sales of prescription drugs (e.g., $4
generic drugs) to pharmacy-benefit managers (PBMs). Since
our study design included an impact of these strategies on
medication adherence from administrative pharmacy data-
bases, we would not have been able to interpret the adherence
modeling results had this variable been included. Mail order
and generic medications are generally tracked in administra-
tive pharmacy databases. Doing something else included too
few individuals to be analyzed as a separate category.
Covariates
Covariates were included to adjust for factors that may have
influenced the outcomes. These covariates included survey
measures of demographics, socioeconomic factors, health sta-
tus and other characteristics taken from health plan eligibility
and claims files. Demographic questions included age, gender,
race and state of residence. Socioeconomic questions
measured living arrangements and education levels (from the
survey) and income levels (geocoded from zip codes to high,
upper medium, lower medium or low income levels). Health
status included body mass index (BMI) categorized to under-
weight (BMI<18.5), normal (BMI 18.5–24.9), overweight
(BMI 25–29) or obese (BMI 30+), smoking status, general
physical health and self-reported treatment of common chron-
ic conditions. Modified Katz Activities of Daily Living
(ADLs; difficulties with bathing, dressing, eating, transferring
in and out of a chair, walking and using the toilet) were
assessed as a measure of disability. ADL disabilities requiring
assistance were categorized as: none, one, two or three or
more. Other sources of drug insurance coverage included
employer insurance or VA insurance. The survey also included
a question on whether the person needed help to complete the
survey and an assessment of confidence in filling out medical
forms, both of which could be considered proxies for health
literacy and/or health condition (e.g., disability). The demo-
graphic, socioeconomic and health status covariates consid-
ered are listed in Table 1.
Propensity Weighting for Survey Non-Response
Bias
Propensity weighting was used to adjust for the potential
selection bias often associated with survey response, to en-
hance the generalizability of these findings. The propensity
weighting utilized available information about the demo-
graphic, socioeconomic and health status variables described
above that could potentially influence survey response. This
information was used to estimate the underlying probability of
survey response for each individual; that estimated probability
was then used to create a weighting variable applied to the data
from those who chose not to respond, to make them better
resemble all eligible insureds. The utility of such propensity
weighting models to adjust for external validity threats is
described elsewhere.35,36
Statistical Models
Survey respondents were categorized into two possible
groups, based on their response to the cost-saving strategies
question: 1) those who utilized cost-saving strategies or 2)
those who reported that they did not need or use such strate-
gies. Propensity weighted multivariate logistic regression
modeling was used to determine significant characteristics
associated with utilization of cost-saving strategies, adjusted
for covariates listed in Table 2.
For the medication adherence analysis, propensity
weighted negative binomial regression modeling was
used to determine significant characteristics associated
wi th medicat ion nonadherence ( i .e . , count of
nonadherent medications) adjusted for covariates listed
in Table 2. Negative binomial models are commonly
used to analyze outcomes, such as event counts, that
have positive integer values with skewed distributions.37
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RESULTS
The overall response rate for the survey was 31 % (N=9,708).
After the inclusion criteria (including self-reported use of
prescription medications andMedicare Part D eligibility) were
applied, 66 % of survey respondents qualified for the study
(N=5,784). Of those, 4,222 (73 %) had required administra-
tive prescription drug claims to be included in the medication










Male 39.8 44.1 37.0 < 0.0001
Race
White 84.6 85.2 84.3 0.33
Age group (years)
65–69 16.0 15.5 16.4 0.38
70–74 24.3 24.9 23.9 0.35
75–79 20.4 21.7 19.6 0.06
80–84 18.3 18.1 18.4 0.80
85 or more 21.0 19.8 21.8 0.07
Income (geocoded from zip code)
High 56.4 57.0 56.0 0.47
Upper middle 22.5 22.2 22.7 0.67
Lower middle 14.9 14.3 15.3 0.27
Lower 6.2 6.5 5.9 0.38
Education
High school or less or missing 34.5 30.3 37.3 < 0.0001
Some college/2 year college 25.9 27.5 24.9 0.03
4 year college or more 28.3 31.0 26.6 0.0003
Living arrangement
Personal home or apartment 83.3 83.7 83.0 0.49
Body Mass Index (BMI)
Under weight (BMI<18.5) 2.3 1.9 2.6 0.06
Normal weight or missing (BMI 18.5–24.9) 30.2 28.8 31.2 0.05
Over weight (BMI 25–29) 31.5 30.9 31.9 0.41
Obese (BMI 30 +) 23.9 26.5 22.2 0.0002
Help completing survey
Yes 8.7 9.6 8.1 0.04
Treated medical conditions
Heart problems 23.2 28.6 19.6 < 0.0001
Stroke 2.2 2.9 1.8 0.007
Lung problems 14.7 21.1 10.5 < 0.0001
Digestive problems 8.3 10.9 6.6 < 0.0001
Musculoskeletal problems 32.0 40.2 26.6 < 0.0001
Diabetes 20.1 25.0 17.0 < 0.0001
Depression 7.2 7.8 6.8 0.14
Cancer 10.7 14.3 8.3 <0.0001
Ever engaged in care management programs
Yes 32.0 35.8 29.5 0.004
Insurance status (self-reported)
Employer’s insurance 3.2 3.4 3.0 0.44
Medicare Part D insurance 74.2 75.1 73.6 0.20
Department of Veterans Affairs insurance 2.6 6.7 0.0 < 0.0001
General physical health
Excellent/very good 29.4 24.0 33.0 < 0.0001
Good 43.2 43.2 43.1 0.94
Poor/fair 27.4 32.8 23.9 < 0.0001
Smoking
Yes 4.1 3.9 4.3 0.44
Activities of daily living (ADLs) requiring assistance
No ADLs 49.9 43.4 54.1 < 0.0001
One ADL 14.9 15.4 14.6 0.35
Two ADLs 12.6 15.0 11.0 < 0.0001
Three or more ADLs 17.9 21.6 15.4 < 0.0001
Have confidence completing medical forms
Yes 79.1 77.2 80.4 0.004
Have difficulty paying for drugs
No 38.4 26.6 46.2 < 0.0001
Number of therapeutic drug classes
0–3 12.8 12.8 22.1 < 0.0001
4–5 22.6 19.2 24.8 < 0.0001
6–7 21.9 23.8 20.7 0.005
8–9 16.9 18.5 15.9 0.008
10 or more 20.2 25.7 16.5 < 0.0001
State of residence (AZ, CA, CO, FL, MO, NJ, NY, NC, OH and TX) was included in the demographics, but not listed in the table for brevity
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adherence modeling. The unadjusted characteristics of the
study sample are shown in Table 2. Overall, survey respon-
dents weremostly female (60.2%), 75 years or older (59.7%),
highly educated (54.2 % some college or more), with high
income (56.4 %) and of white race (84.6 %). The most
common chronic conditions were high blood pressure
(48.1 %) and musculoskeletal problems (32.0 %). Most re-
spondents reported good health (39.8 %). Overall, character-
istics of those in the adherence analysis were similar (data not
shown but available upon request).
Among eligible respondents, 39.6 % indicated they used at
least one of five queried strategies to save money on medica-
tions. Most reported obtaining free samples from doctors
(29.8 %) or splitting pills so medications would last longer
(12.6 %). Over 38 % reported that they did not have difficulty
paying for medications (Table 3).
Characteristics Associated with Use
of Cost-Saving Strategies
The results of the propensity weighted multivariate logistic
regression model used to predict characteristics associated
with use of cost-saving strategies are shown in Table 4. Those
using cost-saving strategies were more likely to be male,
highly educated and white race. Those with more chronic
conditions, including lung problems, musculoskeletal prob-
lems, depression, digestive problems, diabetes and heart prob-
lems, were more likely to use cost-saving strategies. Similarly,
those using more prescription medications (four or more ther-
apeutic classes of prescription medications) and those with
more activities of daily living (ADL) disabilities used the
strategies. Those who had no difficulty paying for medica-
tions, were underweight, minorities and had upper middle
incomes were less likely to use cost-saving strategies.
Characteristics Associated with Medication
Nonadherence
The results of the propensity weighted negative binomial
regression model used to predict characteristics associated
withmedication nonadherence as measured with Part D claims
are shown in Table 5. Few variables were significantly asso-
ciated to medication nonadherence, but those who were
nonadherent were significantly more likely to use more med-
ications, split pills, obtain free samples from their physicians
and to be male. Those more likely to adhere with their med-
ication protocols were more likely to be in very good to
excellent health and to be younger (i.e., 65–74 years).
DISCUSSION
In our study, Medicare Supplement insureds spent on average
$820 OOP on prescription medications, not including Medi-
care Supplement and Part D premiums. Among those taking
medications, 39.6 % utilized cost-saving strategies to reduce
OOP spending on prescription medications. The most
Table 4 Multivariate Logistic Regression Analysis for Use of Cost-
Saving Strategies (N=5,784)
Variables Odds Ratio p value
No difficulty paying 0.45 < 0.0001
Underweight 0.64 < 0.0001
Minority 0.69 < 0.0001
Upper medium income (geocoded) 0.89 0.004
3+ ADLs 1.13 0.02
Age 70–74 years 1.13 0.01
Ever engaged in care management 1.16 0.001
Heart problems 1.17 < 0.0001
Age 75–79 years 1.17 0.002
Live in personal home 1.19 0.005
4–5 Therapeutic drug classes 1.22 < 0.0001
2 ADLs 1.22 < 0.0001
Employer insurance coverage 1.25 0.02
Depression 1.28 < 0.0001
Diabetes 1.29 < 0.0001
Digestive problems 1.29 < 0.0001
Some college 1.41 < 0.0001
Male 1.42 < 0.0001
Musculoskeletal problems 1.43 < 0.0001
8–9 Therapeutic drug classes 1.51 < 0.0001
College 4+ years 1.58 < 0.0001
6–7 Therapeutic drug classes 1.62 < 0.0001
Lung problems 1.63 < 0.0001
10+ Therapeutic drug classes 1.64 < 0.0001
ADLs Activities of Daily Living
Propensity weighted and adjusted for demographic, socioeconomic and
health status variables listed in Table 2
Table 5 Multivariate Binomial Regression Analysis for Medication
Nonadherence (N=4,222)
Variable Odds Ratio p value
Age 65–69 years 0.77 0.05
General health very good to excellent 0.80 0.05
Age 70–74 years 0.83 0.10*
Male 1.18 0.03
Obtain free samples from doctors 1.18 0.04
Ever engaged in care management 1.19 0.06*
6–7 Therapeutic drug classes 1.27 0.07*
“Split pills” so medications last longer 1.45 0.001
8–9 Therapeutic drug classes 1.46 0.006
10+ Therapeutic drug classes 1.65 <0.0001
*Borderline significant p<0.10; Propensity weighted and adjusted for
demographic, socioeconomic and health status variables listed in
Table 2
Table 3 Strategies to Save Money on Medications (N=5,784)
Strategies %
Cost-Saving Strategies
Obtain free samples from doctors 29.8
“Split pills” so medications last longer 12.6
Purchase medications from other countries 3.5
Purchase medications over the internet 2.7
Department of Veterans Affairs insurance coverage 2.6
Any of the above cost-saving strategies 39.6
Other Saving Strategies
Use mail order 37.5
Use generic medications 82.2
Purchase medications from retail outlets 24.1
Did something else 2.5
Don’t have difficulty paying for medications 38.4
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commonly used cost-saving strategy was obtaining free sam-
ples from physicians (29.8 %) followed by splitting pills to
make medications last longer (12.6 %). Those who used cost-
saving strategies were more likely to be male, white, more
highly educated, have more chronic conditions, more disabil-
ities and to take more medications. Consequently, those less
likely to use these strategies were female, minority and had
lower education levels. Thus, demographic and socioeconom-
ic disparities exist in the utilization of these strategies among
Medicare Supplement insureds, likely due to lack of knowl-
edge, expertise and/or communication with physicians.14
Among the cost-saving strategies utilized by older adults to
reduce OOP spending, obtaining free samples from physicians
was the most frequently used strategy in our study and in
others.17–21 Levels of utilization of free samples, however,
were generally about 50 % in representative overall Medicare
populations, somewhat higher than the 39.6%we demonstrat-
ed among this Medicare Supplement study group.18,19,21 This
may be due in part to the higher socioeconomic status of
Medigap beneficiaries (those with upper middle incomes were
less likely to use cost-saving strategies).
Similarly, characteristics associated with the use of any cost-
saving strategies among Medicare Supplement insureds were
reflective of other overall Medicare studies.18–21 Those more
likely to use the strategies were white, had more education, had
more chronic conditions and disabilities and were taking more
medications. These results support the findings that, while
higher OOP spending levels encourage use of cost-saving strat-
egies, those who did utilize the strategies apparently had more
cost-management skills, knowledge and expertise in accessing
these additional medication sources. In contrast, minorities and
lower education individuals were less likely to use cost-saving
strategies, or, in another study, request free samples or have
conversations about medication costs with their physicians.14
Few variables significantly predicted medication
nonadherence in our analysis. However, the strongest predic-
tors included using more medications, splitting pills to make
medications last longer, obtaining free samples from physi-
cians and being male. As in other studies, with the exception
of health status, few demographic or socioeconomic variables
significantly predicted nonadherence.10,16,26–28,30 In our re-
sults, men were more likely to use untrackable cost-saving
strategies, and consequently, were also more likely to be
nonadherent. Consistent with most studies, taking more med-
ications was highly predictive of nonadherence: as the cost
burden of purchasing more medications increased,
nonadherence also increased.23–27,29
Medication adherence is a complex behavior with few
characteristics, beyond cost-related issues, that remain consis-
tent across populations. Since reasons for medication
nonadherence vary by individual, designing effective inter-
ventions to minimize medication nonadherence must also be
multi-faceted. From the patient perspective, education efforts
should focus on increasing disease-related knowledge and
encouraging communications with physicians on cost-related
issues.15,16 Reminder programs remain essential, since forget-
ting to take or refill medications are primary reasons for many
older adults’ nonadherence.30,33 Prescription medication pro-
gramsmay need to incorporate culturally sensitive materials to
address differences in knowledge, attitudes and health beliefs
that influence medication decisions.30 From the provider per-
spective, greater awareness of patient prescription cost issues
must inform prescription medication choices.12,15,33 In addi-
tion, physician, pharmacist or nurse drug review programs
would be helpful in assessing overall drug protocols and/or
the review of purchasing patterns for prescription medications.
Limitations
Our study sample of AARP Medicare Supplement insureds
included a sampling strategy to oversample those with health
issues; thus, our results may not generalize to all Medicare
Supplement populations. However, propensity weighting was
utilized to adjust for non-response bias, so results should be
generalizable to the sampled population. Also, the survey
questions on cost-saving strategies did not query reasons for
selected actions. For example, many free samples may have
been used to try new medications rather than to address cost-
related issues.21 Similarly, pill splitting can be a cost-saving
strategy by design, with scored pills meant to be split, main-
taining prescribed dosages, rather than self-determined split-
ting of pills to make medications last longer. Overall, although
92 % of survey respondents self-reported taking prescription
medications, only 73 % had documented pharmacy claims in
the Part D administrative database. This discrepancy is in line
with expectations from the scientific literature,7 and may be
due to either an overestimation of self-reported medication
consumption,7,38 or an underestimation from pharmacy claims
because of untrackable sources, under-reporting by retail out-
lets, or other insurance coverage of those medications.7
CONCLUSION
Cost-saving strategies are used extensively by Medicare Sup-
plement insureds to augment their Part D coverage. Disparities
are evident in that females, minorities and those with lower
education levels are less likely to benefit from cost-saving
strategies. While use of alternative sources of prescription
drugs can be helpful in managing OOP drug costs, these
untrackable sources of prescription medications are associated
with measured medication nonadherence. Pharmacy and case
management programs should consider these additional med-
ication sources in interventions that assist plan members in
managing their medication protocols and in helping them to
solve cost-related issues.
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